In this episode of the Solar Maverick Podcast, host Benoy Thanjan sits down with Marty McKewon, Director of Renewable Energy and Chief Meteorologist at Indji Systems, during RE+ Las Vegas, the largest renewable energy conference in North America.Marty shares his expertise on how extreme weather events like hail, hurricanes, lightning, and other climate-driven risks how impact solar energy production and what operators can do to mitigate these threats. The conversation highlights the growing

Erik Bloomquist, Wanjie Sun, Yingwen Dong, and Jonathan Moscovici discuss what occurs behind the curtain at the Regulatory-Industry Statistics Workshop.

The story of Certis Oncology begins with a patient. In 2012, Barney Berglund was diagnosed with a rare sarcoma. Standard treatments failed him, and though his doctors at UCLA tried to create mouse avatars of his tumor to test drugs, Barney passed away before the models were ready. Out of his family’s grief came a mission: to change the trial-and-error nature of cancer treatment. They joined with physician-scientists and entrepreneur Peter Ellman to found Certis.* Chapters:* 0:00 What are PDx

Matt and Kevin take a humbling look back a classic 1989 immunology paperfrom the lab of David Baltimore (RIP) in which the gene encoding RAG-1, one of two genes that is responsible for the VDJ recombination - a mechanism for the generation of diversity in the adaptive immune system.

For his first interview as CEO of Myriad Genetics, Sam Raha joined us to help kick off Mendelspod’s 15th season. Raha, who took the helm in April after serving as COO and holding senior roles at Illumina and Agilent, leads Myriad at a pivotal moment. While consumer genomics has faltered—23andMe filed for bankruptcy earlier this year—Myriad continues to double down on its clinical strategy with new offerings in oncology, prenatal testing, and mental health.* 0:00 New MRD and HRD testing* 5:30 What

Episode Summary:In this special episode, Solar Maverick Podcast co-host Li Wang turns the microphone on Benoy Thanjan, who shares his experience as a 9/11 survivor and how that day changed the course of his life. Benoy recounts being inside the World Trade Center when the first plane hit, the chaos of escaping, and the lasting impact of witnessing tragedy up close. He opens up about gratitude, resilience, and how the experience pushed him to pursue work that makes a difference. Key Takeaways Living

#268: Dr. Michelle Dulake — the practicing veterinarian who co-founded Fera Pets supplements and devises all the formulations — talks about how she created feline supplements to address the special and specific health needs of cats, from immune system support to kidney disease.

Catching a cancer relapse before any scan could see it is the ultimate goal for minimal residual disease or MRD testing. And it’s the promise behind Foresight Diagnostics, a Stanford spin-out co-founded by scientist Jake Chabon and oncologist David Kurtz who say they have arrived at “next gen” MRD testing. In this debut interview, Jake and Dave walk us through their journey from academic research to launching one of the most sensitive MRD tests on the market—one that’s already shaped new NCCN

Episode Summary:Tim Montague, host of Clean Power Hour and author of Wired for Sun: The Commercial Solar Playbook, joins Benoy to share how commercial solar projects can be structured for long-term success. The conversation covers how to quickly qualify opportunities, manage interconnection risk, and scope EPC contracts to protect margins. Tim also breaks down how the Big Beautiful Bill influences C&I project economics and what developers can do to scale repeatable business models in 2025 and

Epigenetics has emerged as one of the most revealing windows into cancer biology. Long before genetic mutations appear, changes in DNA methylation can initiate tumorigenesis, shape tumor diversity, and provide powerful clues for biomarker discovery.In this episode of Mendelspod, we explore Illumina’s new 5-base solution with Dr. Bodour Salhia, a cancer epigenetics researcher at USC’s Keck School of Medicine, and Danielle Goldberg, senior product manager at Illumina. The conversation brings together

In this podcast Teresa Rosa discusses the article "Outcome and survival of septic arthritis treated with 0.05% chlorhexidine solution: Description of 10 cases".

Episode Summary: In this episode of the Solar Maverick Podcast, host Benoy Thanjan sits down with Daniel Dus, CEO of Clean Tech Industry Resources (CIR) and founder of Solar Fight Night. Daniel shares his unique perspective on how his company is reshaping solar development through “Development as a Service” and “Construction as a Service” models, making it easier for developers, financiers, and EPCs to scale projects efficiently. Benoy and Daniel dive into industry trends, lessons learned from years

There are numerous social and structural vectors for disease that are not often discussed in medical school. So, Dr. David Ansell says he had a lot to learn once he became a physician.Ansell, author of “The Death Gap: How Inequality Kills,” writes about the stark disparities in access to treatment and outcomes for patients in the U.S. healthcare system. “We always talk about inequities. We have frank inequities, but we have gross inequalities,” Ansell says. “The care isn't equal… And if we could

Howdy bug lovers! On today's episode, Jody and Jonathan talk about the green world and how insects have helped to form it. There's lot of discussion on plant and insect evolution and how an "evolutionary arms race" has heled to create the world as we know it. If you would like to read along with some of the papers referenced in the episode, here are some links that should provide free access. Ehrlich &

Reinventing PCR, huh? That’s what we asked Pranav Patel, CEO and co-founder of N6 Tec, on today’s show. After all, PCR is one of the oldest tools in the molecular biology toolbox. Isn’t that field… done?Turns out, not at all.Patel — a veteran of PacBio, 10x Genomics, and founder of 2D Genomics — is back with a bold rethink of thermocycling itself. His new platform, IconPCR, isn’t just another black box with 96 wells. It’s the first of its kind to feature independently controlled wells, enabling

Today we sit down with renowned geneticist David Ledbetter, whose pioneering work helped uncover the chromosomal basis of Prader-Willi, Angelman, and Miller-Dieker syndromes. He served as Chief Scientific Officer at Geisinger, where he led the MyCode Community Health Initiative—one of the largest population genomic screening programs in the world. Now, he's bringing his decades of experience to bear on a bold new initiative: the Institute for Pediatric Rare Diseases at Florida State

This month Sam speaks to Dr Hanna van Waart and Dr Marta Seretny about what we mean by prehabilitation and how this applies within different cancer populations. They discuss the holistic nature of prehabilitation and how increasing evidence is showing a wide range of benefits even when the intervention time is short. Related Article

Join the EAST In the Arena crew as they talk about the trauma systems in Canada with Dr. Evan Wong of McGill University and Dr. Nori Bradley of the University of British Columbia. We will compare and contrast the Canadian Trauma System with the U.S., the size and scope of rural trauma in Canada, and the unique aspects of a nationalized system of care!

Someone made an AI-based "virtual lab" to engineer nanobodies -is this a paradigm shift in how we do science, or a transpararent and cynical effort to slurp up all of the citations for being first? Por que no los dos?

In this special tribute episode, Mendelspod honors the life and legacy of Dr. Atul Butte (1969-2025), a towering figure in big data and precision medicine who passed away earlier this year. Atul was more than a pioneer in translational bioinformatics—he was a mentor, a builder, and a boundless source of ideas. He sought to “lift all boats in the harbor.”Joining the conversation are three scientists who worked closely with him and continue to carry forward his vision:* Dr. Marina Sirota, UCSF